Repurposing Doxycycline to Overcome High‐Glucose–Induced Mitochondrial Biogenesis–Mediated Chemoresistance in Colorectal Cancer Cells
Journal of Cellular and Molecular Medicine · 2025
DOI: 10.1111/jcmm.70795 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cellular and Molecular Medicine, 2025. Verfasst von Chang-Han Wu und 10 weiteren Autor:innen. Beteiligte Einrichtung: Division of Colorectal Surgery, Department of Surgery, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Drug Resistance, Neoplasm, Glucose, Doxycycline. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Science and Technology Council.
Abstract (Originalsprache)
Chemoresistance is a major contributor to treatment failure in most patients with cancer. Hyperglycaemia enhances chemoresistance in stage III colorectal cancer (CRC) patients, potentially through a mechanism involving c‐Myc. Phospho‐PGC‐1α (p‐PGC‐1α), a transcription coactivator, regulates energy metabolism with c‐Myc and is a key regulator of mitochondrial biogenesis. We hypothesised that high glucose (HG) promotes mitochondrial biogenesis by upregulating c‐Myc and p‐PGC‐1α, thus enhancing chemoresistance in CRC cells, and that inhibiting mitochondrial biogenesis alleviates this chemoresistance. In vitro, HG significantly increased mitochondrial mass ( p < 0.001), oxygen consumption rate ( p < 0.001), cell migration ( p < 0.05) and oxaliplatin resistance ( p < 0.001) in LoVo and HCT116 cells. p‐PGC‐1α and COX4 protein expression were increased in the HG and oxaliplatin‐resistance groups in LoVo and HCT116 cells (all p < 0.001) and decreased in the doxycycline group ( p < 0.001). In vivo, doxycycline combined with oxaliplatin more notably reduced tumour volume than oxaliplatin alone in hyperglycaemic BALB/c nude mice ( p < 0.05). c‐Myc, p‐PGC‐1α and COX4 protein expression were significantly higher in tissues with CRC and hyperglycaemia who experienced relapse than in those with CRC and normoglycaemia who did not experience relapse (all p < 0.05). Overall, this study demonstrated that HG upregulates p‐PGC‐1α and COX4 expression to enhance oxaliplatin resistance by promoting mitochondrial biogenesis and indicates that doxycycline can overcome the chemoresistance induced by HG. Repurposing of doxycycline might reduce chemoresistance in hyperglycaemic CRC patients receiving adjuvant chemotherapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Colorectal Surgery, Department of Surgery, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan.
- Department of Surgery, Faculty of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.
- Graduate Institute of Clinical Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.
- Department of Surgery, Faculty of Post-Baccalaureate Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.
- Division of Colorectal Surgery, Department of Surgery, Kaohsiung Medical University Ganhshan Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan.
- Division of Trauma and Surgical Critical Care, Department of Surgery, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan.
ORCID-Profile: Jaw-Yuan Wang
Förderung
- National Science and Technology Council
Zitieren
APA
Wu, C. H., Huang, C. W., Chen, Y. C., Yip, K. L., Miao, Z. F., Su, W. C., Chang, T. K., Tsai, H. L., Yeh, Y. S., Liu, H. S., & Wang, J. Y. (2025). Repurposing Doxycycline to Overcome High‐Glucose–Induced Mitochondrial Biogenesis–Mediated Chemoresistance in Colorectal Cancer Cells. Journal of Cellular and Molecular Medicine. https://doi.org/10.1111/jcmm.70795
Vancouver
Wu CH, Huang CW, Chen YC, Yip KL, Miao ZF, Su WC, et al. Repurposing Doxycycline to Overcome High‐Glucose–Induced Mitochondrial Biogenesis–Mediated Chemoresistance in Colorectal Cancer Cells. Journal of Cellular and Molecular Medicine. 2025. doi:10.1111/jcmm.70795
BibTeX
@article{Wu2025,
author = {Wu, Chang-Han and Huang, Ching-Wen and Chen, Yen-Cheng and Yip, Kwan-Ling and Miao, Zhi-Feng and Su, Wei-Chih and Chang, Tsung-Kun and Tsai, Hsiang-Lin and Yeh, Yung-Sung and Liu, Hsiao-Sheng and Wang, Jaw-Yuan},
title = {Repurposing Doxycycline to Overcome High‐Glucose–Induced Mitochondrial Biogenesis–Mediated Chemoresistance in Colorectal Cancer Cells},
journal = {Journal of Cellular and Molecular Medicine},
year = {2025},
doi = {10.1111/jcmm.70795}
}
EUVIMED